Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

Presentation

Data-Driven Advocacy: Leveraging DataDerm for Dermatology's Future

Description

The discussion highlights the significance of DataDerm, the largest dermatology data registry globally, in supporting advocacy efforts within dermatology. Dr. Bruce Brod introduces DataDerm as a critical tool for generating necessary data to influence policymakers and insurance companies regarding dermatological care. Since its launch in 2016, DataDerm has accumulated extensive data from over 16 million unique patients and 68 million visits, allowing dermatologists to benchmark their practices and improve care standards. The registry collects diverse clinical information, although it is noted that it currently has some limitations in data types. The collaboration with OM1 enhances the analytical capabilities of DataDerm, allowing for a deeper understanding of patient journeys. Key advocacy successes are showcased, such as using DataDerm data to counter inefficient policies from insurance companies and demonstrating the appropriate use of phototherapy across various dermatological conditions. As DataDerm evolves, it offers potential for improved research, quality improvement, and effective advocacy. The ownership of this data is emphasized as empowering dermatologists to better support their practices and enhance patient outcomes. Overall, DataDerm is portrayed as a pivotal resource for advancing dermatology through data-driven advocacy.

View more

Conclusions

DataDerm is a powerful tool for dermatology advocacy, enabling the generation of evidence-based narratives to influence policy and insurance coverage.
The registry has collected extensive data from millions of patients, providing dermatologists with valuable insights into practice benchmarking and quality of care.
DataDerm is essential for effective communication with insurance companies and policymakers by demonstrating adherence to treatment guidelines.
The collaboration with OM1 enhances DataDerm by integrating data from various sources, improving the comprehensiveness of dermatologic care insights.
DataDerm can help track the real-world impact of policy changes, such as those affecting photodermatology, by analyzing usage patterns across various diagnoses.
The platform aids in informing education efforts by providing feedback on how well dermatologists adopt new coding and treatment practices after training sessions.
DataDerm supports ongoing research initiatives, helping identify trends and patterns over time in dermatologic conditions and treatments.
The expansion of the DataDerm platform to better serve the dermatology community will enhance its utility in protecting payments and optimizing care delivery.

American Academy of Dermatology Association, AAD's DataDerm clinical data registry, launched in 2016, began as a comprehensive, dermatology-owned data collection platform that sought to aggregate data from dermatologists nationwide to inform dermatology-specific quality improvement.
DataDerm is the largest dermatologic clinical data registry in the world.